1. An insulin-producing cell line, RINm5F, derived from a rat insulinoma was studied. 2. The cellular content of immunoreactive insulin was 0.19 pg/cell, which represents approx. 1% of the insulin content of native rat fl-cells, whereas that of immunoreactive glucagon and somatostatin was five to six orders of magnitude less than that of native aor 6-cells respectively. 3. RINm5F cells released 7-12% of their cellular immunoreactive-insulin content at 2.8 mM-glucose during 60 min in Krebs-Ringer bicarbonate buffer. 4. Glucose utilization was increased by raising glucose from 2.8 to 16.7 mm. There was, however, no stimulation of immunoreactive-insulin release even when glucose was increased from 2.8 to 33.4mM. A small stimulation of release was, however, found when glucose was raised from 0 to 2.8mm. 5. Glyceraldehyde stimulated the release of immunoreactive insulin in a dose-dependent manner. 6. At 20mm, leucine or arginine stimulated release at 2.8mM-glucose. 7. Raising intracellular cyclic AMP by glucagon or 3-isobutyl-1-methylxanthine stimulated release at 2.8mM-glucose with no additional stimulation at 16.7mM-glucose. 8. Stimulation of immunoreactive-insulin release by K+ was dose-related between 2 and 30mm. Another depolarizing agent, ouabain, also stimulated release. 9. Adrenaline (epinephrine) inhibited both basal (2.8mM-glucose) release and that stimulated by 30mM-K+. 10. Raising Ca2+ from 1 to 3mm stimulated immunoreactive-insulin release, whereas a decrease from 1 to 0.3 or to 0.1 mM-Ca2+ lowered the release. 1 1. These findings could reflect a relatively specific impairment in glucose handling by RINm5F cells, contrasting with the preserved response to other modulators of insulin release.
The use of isolated islets of Langerhans as an experimental tool has greatly advanced our understanding of the function of the pancreatic fl-cell (Hedeskov, 1980; Ashcroft, 1980; Wollheim & Sharp, 1981) . However, for the characterization of the mechanism and the regulation of insulin production and release at a more molecular level than has been achieved to date, large quantities of cellular material are required. This is not practical using isolated islets or primary cultures of islet cells, which display only limited proliferative capacity (Rabinovitch et al., 1980) . One potentially attractive source of cells for such studies would be an insulinproducing cell line, and, indeed, attempts have been made to obtain such lines by using a variety of techniques (Adcock et al., 1975; Niesor et al., 1979; Santerre et al., 1981; Rae et al., 1979) . Clearly, an insulin-producing cell line will only be of value if the cells retain full differentiated function in parallel with their ability to proliferate in culture.
The present study was undertaken to investigate the functional characteristics of an insulin-producing cell line, RINm5F Bhathena et al., 1982) , derived from a rat islet-cell tumour (Chick et al., 1977) . To this end the response of these cells to a variety of agents known to stimulate or inhibit insulin release from native pancreatic fl-cells was examined.
Methods

Cell culture
The insulin-producing cell line (RINm5F) used in this study was generously provided by Dr. D. H. Mintz, University of Miami, FL, U.S.A., by courtesy of Dr. A. Gazdar, Georgetown University, Washington, DC, U.S.A. This cloned line was established in culture after a nude-mouse heterotransplant of an X-ray-induced transplantable rat islet tumour Bhathena et al., 1982) .
The cells were grown in plastic culture bottles in RPMI 1640 medium supplemented with 10% (v/v) foetal-calf serum, 100i.u. of penicillin/ml, 100ug of streptomycin/ml and 0.25,pg of fungizone/mi. Cells were seeded at a density of 2.5 x 104 cells/ml in a total volume of 10 or 20ml of medium for 25cm2 and 75 cm2 culture bottles respectively. The medium was changed every 3 days and the cells were detached from the bottles with trypsin 1 week after seeding [0.025% trypsin in Ca2+/Mg2+-free physiological saline (0.9% NaCl)/0.27mM-EDTA, 3-7min at 370C]. The trypsin-treated cells were then diluted appropriately for reseeding in culture bottles or in Petri dishes or test plates as described below. The mean population doubling time in exponential growth phase was of the order of 48 h. (Herbert et al., 1965) as detailed elsewhere (Trimble & Renold, 1981) . Rat insulin, pig glucagon and synthetic cyclic somatostatin were used as standards. Guinea-pig anti-(pig insulin) serum was generously given by Dr. A. Lernmark, Hagedorn Research Laboratory, Gentofte, Denmark. Rabbit anti-(pig glucagon) serum (BR 124) was raised in rabbits in our laboratory (Trimble et al., 1982) . Rabbit antisomatostatin serum was generously provided by Dr. F. Jeanrenaud-Rohner, University of Geneva, Geneva, Switzerland.
In order to estimate the apparent molecular weight of immunoreactive insulin extracted from RINm5F cells, portions of cell extracts were subjected to column chromatography. To this end, cell extracts in 1 M-acetic acid/bovine serum albumin (2.5 mg/ml) were neutralized with 1 M-NaOH and then applied to a Sephadex G-50 (Fine grade) column (dimensions 1 cm x 80cm) and eluted with 0.2 M-glycine/bovine serum albumin (2.5 mg/ml), pH 8.8. The fractions eluted from the column were then taken for radioimmunoassay in order to measure the immunoreactive insulin. The column was characterized by using native pig insulin as a marker. Glucose utilization Glucose utilization was measured by monitoring the conversion of [5-3Hlglucose to 3H20 (Ashcroft et al., 1972) . Cells were incubated in 1 ml of KRB/Hepes containing 1 pCi of [5-3H]glucose/ml (stock specific radioactivity 15.6 Ci/mmol) and either 2.8 or 16.7 mM-glucose. After 60min at 370C, the buffer was removed and centrifuged as above to remove any detached cells. Portions of the buffer (200,u) were then taken to measure the production of 3H20 during the incubation period, a method described in detail previously (Halban et al., 1980) being used.
Presentation ofdata
Results are expressed as means + S.E.M. The statistical significance for differences between groups was determined by Student's t-test for unpaired data.
Sources ofmaterials
The materials used in the present study were obtained as follows: RPMI 1640 medium, fungizone, Effects of glucose on short-term release of immunoreactive insulin and on glucose utilization RINm5F cells were incubated for 30min with concentrations of glucose ranging from 0 to 33 mM (Fig. 1) . There was a stimulation of release of immunoreactive insulin of approx. 50% when the glucose concentration was raised from 0 to 1.4 mM, but no further stimulation was seen at higher glucose concentrations.
In order to determine whether the cells were able to metabolize glucose and to respond to changes in glucose concentration with altered rates of glucose metabolism, glucose utilization was studied in parallel with immunoreactive-insulin release over 60min. An increase in glucose from 2.8 to 16.7mM stimulated glucose utilization by 55% without any significant concomitant change in immunoreactiveinsulin release (Table 1) .
Effects of glyceraldehyde and amino acids on immunoreactive-insulin release
The effects of other known stimulators of insulin release were also studied. Glyceraldehyde has been shown to mimic the effects of glucose on islet function (Jain et al., 1975) . For RINm5F cells it was found that glyceraldehyde (in the presence of 2.8mM-glucose) stimulated the release of immunoreactive insulin by approx. 100% (Fig. 2) . Both D-glyceraldehyde ( Fig. 2a) and DL-glyceraldehyde (Fig. 2b) A comparable degree of stimulation of immunoreactive-insulin release was found when the cells were exposed to 20 mM-L-leucine or 20 mM-Larginine in the presence of 2.8 mM-glucose (Table 2) . Effects ofglucagon and 3-isobutyl-J-methylxanthine on immunoreactive-insulin release Next, the influence of two substances known to raise islet intracellular cyclic AMP levels was tested.
Both glucagon (lug/ml, 0.33 pm; Table 3 , Series I) and 3-isobutyl-l-methylxanthine (1 mm, Table 3 , Series II) stimulated immunoreactive-insulin release by 50 to 100%. No additional stimulatory effect of either substance was observed when glucose was raised from 2.8 to 16.7mM.
Effects of K+, ouabain and Ca2+ on immunoreactive-insulin release
It is well-established that islet cells are extremely sensitive to changes in their cationic environment (Wollheim & Sharp, 1981) . For RINm5F cells, the effects of two cations (K+ and Ca2+) were studied. In both cases, lower and higher concentrations of the ions were used than those encountered in the standard KRB/Hepes buffer (namely 6mM-K+ and 1 mM-Ca2+).
At 2.8 mM-glucose there was no significant stimulation of immunoreactive-insulin release when K+ was raised from 2 to 4 mm (Fig. 3) . However, a stimulation of release was found upon increasing K+ in turn from 4 to 6mM and from 6 to 15mM. The effects of lowering or increasing K+ were also tested in paired experiments at 16.7 mM-glucose. Whereas the sensitivity to increasing K+ was comparable with that seen at 2.8mM-glucose (Fig. 3) , it was found that 16.7mM-glucose elicited a small, but significant (P <0.005), stimulation of immunoreactive-insulin release at 2 mM-K+ compared with 2.8 mM-glucose at the same low ambient K+. Another substance known, like K+, to depolarize and stimulate insulin release from islets is ouabain . When tested at 2.8 mM-glucose, 1 mM-ouabain increased immunoreactive-insulin release from 9.9 + 0.8 to 18.0 + 0.9 ng/60 min per well (n = 12).
A decrease in Ca2+ (at 2.8mM-glucose) from 1 to 0.3 mm resulted in a significant (P < 0.01) decrease in (Table 4) . Adrenaline (1 LM) inhibited release of immunoreactive insulin at 2.8 mMglucose by approx. 50%. A significant, but less marked, inhibition of release was observed with 10nM-adrenaline (result not shown). When release was stimulated by K+, adrenaline caused a marked reduction in release. However, even in the presence of adrenaline, K+ still stimulated release, albeit to a lesser extent than that observed in the absence of the catecholamine (Table 4) .
Discussion
Previous attempts to obtain insulin-producing cell lines have met with limited success. Thus, when cells from human insulinomas are established in culture, there is most commonly a time-dependent decrease in cellular insulin content, the cells usually becoming completely de-differentiated after several culture passages (Yip & Schimmer, 1973; Adcock et at., 1975 ). An alternative approach has been to infect pancreatic ,-cells with Simian virus 40. In our hands, such Simian-virus-40 transformation of neonatal-rat fl-cells did not produce a suitably differentiated cell line (Niesor et al., 1979) . More recently, it has been reported that Simian-virus-40 infection of hamster fl-cells resulted in cell lines with retained functional capacity, but the cellular insulin content of these cells decreased with time (Santerre et al., 1981) . The RINm5F cells used in the present study were originally derived from a rat insulinoma and have been partially characterized previously. It has thus been shown in the original paper describing several sublines related to RINm5F, that insulin production fluctuated with time in culture, whereas after cloning, lines with relatively enriched levels of either insulin or somatostatin were obtained (Bhathena et al., 1982) . We found that RINm5F cells contain levels of immunoreactive insulin which remain constant over more than 1 year in culture. The cellular content of immunoreactive insulin is, however, only 0.19 pg/ cell. For native f-cells, it can be calculated, taking the insulin content of adult rat islets (Trimble & Renold, 1981) and the relative number of fl-cells in Vol. 210 such islets (Baetens et al., 1979) , that the insulin content is 22pg/fl-cell. RINm5F cells thus contain approx. 1% of the immunoreactive-insulin content of native rat fl-cells.
It has been reported by others (Bhathena et al., 1980 (Bhathena et al., , 1982 that RINm5F cells also contain immunoreactive glucagon and somatostatin. By using a calculation similar to that applied to insulin, it can be shown that RINm5F cells contain five to six orders of magnitude less glucagon or somatostatin than do native a-or 5-cells. Indeed, even these very low values may prove to be an overestimate, since the absolute values measured [even when (1-2) x 10-7 cells were extracted] proved variable from one culture flask to the next, some flasks revealing no measurable glucagon or somatostatin. It should be noted that no such variability was found for immunoreactive-insulin cellular content when measured in parallel. These exquisitely low levels of glucagon or somatostatin, taken with the described variability, beg the question as to the significance of these findings. If correct, however, these data could indicate that RINm5F cell cultures contain small numbers of cells producing other islet hormones.
Throughout the present paper we refer exclusively to insulin as determined by radioimmunoassay ('immunoreactive insulin'). It has been shown that immunoreactive material extracted from RINm5F cells has a molecular size by chromatography consistent with that of native proinsulin and insulin and, furthermore, the immunoreactive product(s) dilute in a linear fashion relative to native rat insulin in the radioimmunoassay. It cannot yet be completely excluded that the immunoreactive material studied is a cell product closely related to, but not identical with, insulin.
The main purpose of the present study was to examine the regulation of insulin release from RINm5F cells. Although immunoreactive insulin release was stimulated to a limited extent by glucose (only under certain conditions), this effect was quite different from that with normal pancreatic fl-cell preparations [for reviews, see Hedeskov (1980) and Wollheim & Sharp (1981) 1. Thus release was only stimulated by 50% and this stimulation arose at very low glucose concentrations (in contrast with native fl-cells, which display an apparent Km for glucose stimulation of insulin release in the range of 8 mM).
Whereas there was no stimulation ofimmunoreactiveinsulin release between 2.8 and 16.7 mM-glucose, glucose utilization by RINm5F cells was increased by 55%, suggesting that these cells are not glucoseinsensitive, even in this concentration range. In contrast with glucose, the triose, glyceraldehyde, stimulated immunoreactive insulin in a dose-related manner, and the sensitivity of RINm5F cells is comparable with that found in rat islets (Jain et al., 1975) , albeit with reduced responsitivity in terms of maximal stimulation of release. One possible explanation for this could be the high rate of immunoreactive-insulin release under basal conditions (2.8 mM-glucose alone), which amounts to 7-12% of the cellular immunoreactive-insulin content/h. This value is considerably higher than that found in normal fl-cell preparations , and this is perhaps consistent with the observation that adrenaline inhibits basal release from RINm5F cells, but not from another preparation of cultured cells, monolayer cultures of newborn-rat pancreatic cells (Marliss et al., 1973) . It is currently thought that phosphorylation of glucose by fl-cell glucokinase is the rate-limiting step for glycolysis, and, in turn, glucose stimulated insulin release (Hedeskov, 1980; Trus et al., 198 1; Trueheart-Burch et al., 1981) . The present data on RINm5F cells could imply a defect at this step, when it is recalled that glucose utilization by islet cells has been shown to correlate well with the rate of glucose phosphorylation (Trus et al., 1981) . If such a defect is indeed responsible for the lack of glucose sensitivity of RINm5F cells, then substrates which act distal to glucose phosphorylation would be expected to stimulate insulin release. This was found for glyceraldehyde (as discussed above), and for a substance of physiological importance, leucine. It should be noted that the rat islet-cell tumour from which the RINm5F cells originate (Chick et al., 1977) shows increased immunoreactive-insulin release in response not only to leucine (Sopwith et al., 1981) but also to glucose (Masiello et al., 1982) . A further interesting facet of the control of insulin production is the observation that, in the rat, only one of the two insulin-gene products is subject to glucose control (Kakita et al., 1982a) ; it will thus be important in future studies to analyse the ratio of rat insulins I and II (Kakita et al., 1982b) It is noteworthy that there are other situations where glucose elicits only a poor stimulation of insulin release, whereas glyceraldehyde is found to be fully active. For islets of newborn animals (Agren et al., 1976) an increase in glucose from 0 to 1.4mM stimulated insulin release, whereas no further stimulation was found at higher glucose concentrations. These data are strikingly similar to those for RINm5F cells presented here. In addition, islets from the newborn animals responded well to glyceraldehyde. The other cases where only a poor response to glucose is observed in the face of retained sensitivity towards glyceraldehyde are in islets from starved animals (Lipson et al., 1979) and from New Zealand obese (NZO) mice (Larkins et al., 1980) . Since in these three cases cyclic AMP partially restored glucose sensitivity, this phenomenon was tested in RINm5F cells. Both glucagon and 3-isobutyl-1-methylxanthine (two agents known to raise intracellular cyclic AMP levels) were found to stimulate immunoreactive-insulin release from RINm5F cells, but there was no difference in release between 2.8 and 16.7mM-glucose, even in the presence of these substances.
An increased concentration of cytosolic Ca2+ in the fl-cell is thought to trigger insulin release (Wollheim & Sharp, 1981) . A simple demonstration of this is to depolarize cells with elevated K+ which, in turn, results in Ca2+ influx through voltagesensitive Ca2+ channels (Atwater et al., 1981; Wollheim et al., 1980) . Raising K+ from 6 mM to 15 or 30mM caused a marked increase in immunoreactive insulin release from RINm5F cells. Indeed, this degree of stimulation was higher than that for any other condition used. For these cells, the membrane potential would seem to be an important factor in the regulation of release, since a lowering of K+ from 6 to 2 mm lowered immunoreactive-insulin release. Furthermore, at 2 mM-K+, 16.7 mM-glucose caused a small stimulation of release not observed at higher K+ concentrations.
In normal pancreatic fl-cells, Ca2+ alone can only induce insulin release under certain conditions, e.g. pretreatment with extremely low Ca2+ followed by very high Ca2+ (for review, see Wollheim & Sharp, 1981 (Kaplan et al., 1979) rather than that of native fl-cells.
In conclusion, RINm5F cells, although displaying a number of differentiated features typical of native fl-cells, appear to suffer from certain aberrations in their regulation of immunoreactive-insulin release. The study of these changes may provide further insight into the regulation of insulin release normally occurring in fl-cells.
